All Stories

  1. The H2S Donor GYY4137 Stimulates Reactive Oxygen Species Generation in BV2 Cells While Suppressing the Secretion of TNF and Nitric Oxide
  2. Anti-encephalitogenic effects of ethyl pyruvate are reflected in the central nervous system and the gut
  3. Anti-encephalitogenic effects of cucumber leaf extract
  4. Strain-specific helper T cell profile in the gut-associated lymphoid tissue
  5. Pomegranate peel extract ameliorates autoimmunity in animal models of multiple sclerosis and type 1 diabetes
  6. Cell-based Tolerogenic Therapy, Experience from Animal Models of Multiple Sclerosis, Type 1 Diabetes and Rheumatoid Arthritis
  7. Correlation of Gut Microbiota Composition with Resistance to Experimental Autoimmune Encephalomyelitis in Rats
  8. Cucurbitacin E Potently Modulates the Activity of Encephalitogenic Cells
  9. Gut-associated lymphoid tissue, gut microbes and susceptibility to experimental autoimmune encephalomyelitis
  10. The NO-modified HIV protease inhibitor as a valuable drug for hematological malignancies: Role of p70S6K
  11. Cell death of spinal cord ED1 + cells in a rat model of multiple sclerosis
  12. Micro RNA-155 participates in re-activation of encephalitogenic T cells
  13. Tumor necrosis factor stimulates expression of CXCL12 in astrocytes
  14. Short term exposure to ethyl pyruvate has long term anti-inflammatory effects on microglial cells
  15. Activity, but not mRNA expression of gelatinases correlates with susceptibility to experimental autoimmune encephalomyelitis
  16. A Comparative Analysis of Multiple Sclerosis-Relevant Anti-Inflammatory Properties of Ethyl Pyruvate and Dimethyl Fumarate
  17. Effect of ethyl pyruvate on central nervous system inflammation
  18. Saquinavir-NO Inhibits IL-6 Production in Macrophages
  19. Study of the anticancer properties of methyl- and phenyl-substituted carbon- and silicon-bridged ansa-titanocene complexes
  20. Anticancer Potential of (Pentamethylcyclopentadienyl)chloridoiridium(III) Complexes Bearing κPand κP,κS-Coordinated Ph2PCH2CH2CH2S(O)xPh (x=0-2) Ligands
  21. Synthesis, X-ray structure and strong in vitro cytotoxicity of novel organoruthenium complexes
  22. Multiple Sclerosis: Molecular Mechanisms and Therapeutic Opportunities
  23. Regional cytokine responses to pulmonary aspergillosis in immunocompetent rats
  24. Biological activity of neutral and cationic iridium(III) complexes with κP and κP,κS coordinated Ph2PCH2S(O)xPh (x = 0–2) ligands
  25. The Frequency of Allele CCR5∆32 in a Serbian Population / UČESTALOST ALELA CCR5∆32 U SRPSKOJ POPULACIJI
  26. No-Modified Saquinavir is Equally Efficient Against Doxorubicin Sensitive and Resistant Non-Small Cell Lung Carcinoma Cells / MODIFIKOVANA KOVANA FORMA SAKVINAVIRA EFIKASNO SU PRIMI RA RAST ĆELIJA NESITNOĆELIJSKOG KARCINOMA PLUĆA RAZLIČITE OSETUIVOSTI ...
  27. High interleukin-10 expression within the central nervous system may be important for initiation of recovery of Dark Agouti rats from experimental autoimmune encephalomyelitis
  28. Apotransferrin inhibits interleukin-2 expression and protects mice from experimental autoimmune encephalomyelitis
  29. Nitric oxide inhibits CXCL12 expression in neuroinflammation
  30. CXCL12-γ expression is inhibited in neuroinflammation
  31. Saquinavir-NO inhibits S6 kinase activity, impairs secretion of the encephalytogenic cytokines interleukin-17 and interferon-gamma and ameliorates experimental autoimmune encephalomyelitis
  32. The elimination of P-glycoprotein over-expressing cancer cells by antimicrobial cationic peptide NK-2: The unique way of multi-drug resistance modulation
  33. Betulinic acid regulates generation of neuroinflammatory mediators responsible for tissue destruction in multiple sclerosis in vitro
  34. Antitumor potential of novel betulin derivative on human A375 melanoma cell line
  35. Tenascins and inflammation in disorders of the nervous system
  36. Cell-type dependent response of melanoma cells to aloe emodin
  37. Therapeutic Potential of Nitric Oxide-Modified Drugs in Colon Cancer Cells
  38. CXCL12: Role in neuroinflammation
  39. Effects of subacute oral warfarin administration on peripheral blood granulocytes in rats
  40. Novel methylene modified cyclohexyl ethylenediamine-N,N′-diacetate ligands and their platinum(IV) complexes. Influence on biological activity
  41. Saquinavir-NO-targeted S6 protein mediates sensitivity of androgen-dependent prostate cancer cells to TRAIL
  42. CXCL12 in control of neuroinflammation
  43. Platinum(ii/iv) complexes containing ethylenediamine-N,N′-di-2/3-propionate ester ligands induced caspase-dependent apoptosis in cisplatin-resistant colon cancer cells
  44. Melanoma tumor inhibition by tetrachlorido(O,O′-dibutyl-ethylenediamine-N,N′-di-3-propionate)platinum(iv) complex: in vitro and in vivo investigations
  45. Novel octahedral Pt(IV) complex with di-n-propyl-(S,S)-ethylenediamine-N,N′-di-2-(3-cyclohexyl)propanoato ligand exerts potent immunomodulatory effects
  46. CXCL12 expression within the CNS contributes to the resistance against experimental autoimmune encephalomyelitis in Albino Oxford rats
  47. Contact allergic response to dinitrochlorobenzene (DNCB) in rats: Insight from sensitization phase
  48. It is still not for the old iron: adjuvant effects of carbonyl iron in experimental autoimmune encephalomyelitis induction
  49. Cytotoxic and immune-sensitizing properties of nitric oxide-modified saquinavir in iNOS-positive human melanoma cells
  50. Astrocytes in the tempest of multiple sclerosis
  51. In vitro and in vivo anticancer action of Saquinavir-NO, a novel nitric oxide-derivative of the protease inhibitor saquinavir, on hormone resistant prostate cancer cells
  52. Dry olive leaf extract (DOLE) down-regulates the progression of experimental immune-mediated diabetes by modulation of cytokine profile in the draining lymph nodes
  53. Multiple antimelanoma potential of dry olive leaf extract
  54. Induction of caspase-independent apoptotic-like cell death of mouse mammary tumor TA3Ha cells in vitro and reduction of their lethality in vivo by the novel chemotherapeutic agent GIT-27NO
  55. Dried leaf extract of Olea europaea ameliorates islet-directed autoimmunity in mice
  56. Strain difference in susceptibility to experimental autoimmune encephalomyelitis in rats correlates with TH1 and TH17-inducing cytokine profiles
  57. Effector T cell interactions with meningeal vascular structures in nascent autoimmune CNS lesions
  58. The novel NO-donating compound GIT-27NO inhibits in vivo growth of human prostate cancer cells and prevents murine immunoinflammatory hepatitis
  59. Dry olive leaf extract ameliorates experimental autoimmune encephalomyelitis
  60. The antitumor properties of a nontoxic, nitric oxide-modified version of saquinavir are independent of Akt
  61. Transforming Growth Factor-β1 in Balkan Endemic Nephropathy
  62. T cells cooperate with palmitic acid in induction of beta cell apoptosis
  63. Macrophage migration inhibitory factor stimulates interleukin-17 expression and production in lymph node cells
  64. Methylprednisolone inhibits IFN-γ and IL-17 expression and production by cells infiltrating central nervous system in experimental autoimmune encephalomyelitis
  65. Murine brain endothelial cells differently modulate interferon-γ and interleukin-17 production in vitro
  66. Kinetics of IFN-γ and IL-17 expression and production in active experimental autoimmune encephalomyelitis in Dark Agouti rats
  67. Novel nitric oxide-donating compound (S,R)-3-phenyl-4,5-dihydro-5-isoxazole acetic acid–nitric oxide (GIT-27NO) induces p53 mediated apoptosis in human A375 melanoma cells
  68. Anticancer properties of the novel nitric oxide-donating compound (S,R)-3-phenyl-4,5-dihydro-5-isoxazole acetic acid-nitric oxide in vitro and in vivo
  69. Methylprednisolone inhibits interleukin-17 and interferon-gamma expression by both naive and primed T cells
  70. Macrophage migration inhibitory factor (MIF) is necessary for progression of autoimmune diabetes mellitus
  71. In vitro, ex vivo and in vivo immunopharmacological activities of the isoxazoline compound VGX-1027: Modulation of cytokine synthesis and prevention of both organ-specific and systemic autoimmune diseases in murine models
  72. Astrocytes stimulate interleukin-17 and interferon-γ production in vitro
  73. B9. Tumoricidal activity of GIT-27NO depends on RNS and ROS generation
  74. C20. Novel NO-donation compound GIT-27NO possesses strong tumoricidal capacity in vitro and in vivo
  75. A Potent Immunomodulatory Compound, (S,R)-3-Phenyl-4,5-dihydro-5-isoxasole Acetic Acid, Prevents Spontaneous and Accelerated Forms of Autoimmune Diabetes in NOD Mice and Inhibits the Immunoinflammatory Diabetes Induced by Multiple Low Doses of Streptoz...
  76. Acidosis affects tumor cell survival through modulation of nitric oxide release
  77. Strain difference in susceptibility to experimental autoimmune encephalomyelitis between Albino Oxford and Dark Agouti rats correlates with disparity in production of IL-17, but not nitric oxide
  78. Interleukin-17 stimulates inducible nitric oxide synthase-dependent toxicity in mouse beta cells
  79. Critical Role of Macrophage Migration Inhibitory Factor Activity in Experimental Autoimmune Diabetes
  80. [Pt(HPxSC)Cl3], a novel platinum(IV) compound with anticancer properties
  81. The Mechanisms of 6-Hydroxydopamine-Induced Astrocyte Death
  82. Aloe emodin decreases the ERK-dependent anticancer activity of cisplatin
  83. Iron protects astrocytes from 6-hydroxydopamine toxicity
  84. Anti-glioma action of aloe emodin: the role of ERK inhibition
  85. Novel platinum(IV) complexes induce rapid tumor cell deathin vitro
  86. Novel ruthenium complex K2[Ru(dmgly)Cl4]·2H2O is toxic to C6 astrocytoma cell line, but not to primary rat astrocytes
  87. Iron down-regulates macrophage anti-tumour activity by blocking nitric oxide production
  88. Immunosuppressive and anti-inflammatory action of antioxidants in rat autoimmune diabetes
  89. Taxol activates inducible nitric oxide synthase in rat astrocytes: the role of MAP kinases and NF-?B
  90. Inducible nitric oxide synthase activation by interleukin-17
  91. 5-Aza-2′-deoxycytidine and paclitaxel inhibit inducible nitric oxide synthase activation in fibrosarcoma cells
  92. 5-Aza-2′-deoxycytidine stimulates inducible nitric oxide synthase induction in C6 astrocytoma cells
  93. Astrocyte-induced regulatory T cells mitigate CNS autoimmunity
  94. Mycophenolic acid inhibits activation of inducible nitric oxide synthase in rodent fibroblasts
  95. The role of interleukin-17 in inducible nitric oxide synthase-mediated nitric oxide production in endothelial cells
  96. Decreased Frequency of the Tumor Necrosis Factor α –308 Allele in Serbian Patients with Multiple Sclerosis
  97. Inhibition of autoimmune diabetes by mycophenolate mofetil is associated with down-regulation of TH1 cytokine-induced apoptosis in the target tissue
  98. IMMUNOSUPPRESSANTS LEFLUNOMIDE AND MYCOPHENOLIC ACID INHIBIT FIBROBLAST IL-6 PRODUCTION BY DISTINCT MECHANISMS
  99. Down-regulation of multiple low dose streptozotocin-induced diabetes by mycophenolate mofetil
  100. Mycophenolic acid downregulates inducible nitric oxide synthase induction in astrocytes
  101. Nitric oxide metabolites and interleukin-6 in cerebrospinal fluid from multiple sclerosis patients
  102. Necrotic tumor cells oppositely affect nitric oxide production in tumor cell lines and macrophages
  103. Interleukin-17 stimulates inducible nitric oxide synthase activation in rodent astrocytes
  104. Uric acid levels in sera from patients with multiple sclerosis
  105. Amphotericin B potentiates the activation of inducible nitric oxide synthase and causes nitric oxide-dependent mitochondrial dysfunction in cytokine-treated rodent astrocytes
  106. Leflunomide inhibits activation of inducible nitric oxide synthase in rat astrocytes